Brazil’s CADE to vote on DaVita-Brasnefro deal, four other cases
( April 3, 2025, 12:39 GMT | Official Statement) -- MLex Summary: The Brazilian competition agency has set the schedule for its next ruling session, which will take place on April 9. The agency will rule on five cases, including a deal between DaVita Brasil and Brasnefro in the healthcare market. In addition, four other probes are expected to be voted on by the agency’s Tribunal.See full statement in Portuguese:...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.